About Humanigen Inc.
Humanigen, Inc is a Clinical Stage Biopharmaceutical company developing immunology and immuno oncology portfolio of monoclonal antibodies. It is having 68.3 million USD as on 2020. The headquarters is in USA.
More about Humanigen Inc.
- Acquisitions and changes
- No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,901 (Jan 2022) · #5,472 (Dec 2022)
Lobbying by Humanigen Inc.#
$140 K spent on lobbying the US Congress and federal agencies in 2021, most often on budget/appropriations, health issues and manufacturing.
- Budget/Appropriations3 reports
- Health Issues3 reports
- Manufacturing3 reports
- Medical/Disease Research/Clinical Labs3 reports
Lobbying firms hired in 2021
Van Scoyoc Associates $130 K · HOLLIS PUBLIC AFFAIRS $10 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2021 | $140 K | — | 4 |
| 2020 | $60 K | — | 2 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Humanigen, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Humanigen Inc.🇺🇸 | $13 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Dec 25, 2022 (last known)
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Humanigen Inc.? Verify and update this profile — free
Show Humanigen Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.